You are here: Industry Insights > Breast Cancer

News List

FDA Approves Treatment Option for HER2-Positive Metastatic Breast Cancer americanpharmaceuticalreview
April 21, 2020
As part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Tukysa (tucatinib) in combination with chemotherapy (trastuzumab and capecitabine) for the treatment of ...
Roche’s Atezolizumab receives DCGI approval for treatment of metastatic triple-negative breast cancer in India expresspharma
April 09, 2020
Atezolizumbab is the first immunotherapy drug to be approved globally for treatment of unresectable locally advanced and metastatic triple-negative breast cancer。
BeiGene doses first patient in phase 1b/2 trial of ZW25 in HER2-positive breast cancer and GEA pharmaceutical-business-review
April 06, 2020
Zymeworks announced that its partner, BeiGene has dosed the first patient in a two-arm Phase 1b/2 trial evaluating the former's HER2-targeted bispecific antibody ZW25 in combination with chemotherapy.
Breast cancer ‘breakthrough’ could end unnecessary biopsies pharmatimes
March 10, 2020
European scientists have created a novel mammography imaging system that could potentially “spell an end” to unnecessary biopsies, by determining benign or malignant breast lesions.
Roche HER2-ADC Enmetrastuzumab has been approved for marketing in China En-CPhI.CN
January 19, 2020
Detailed story will be updated soon, please stay tuned with us.
Lack of Insurance Tied to Later Stage of Breast Cancer at Diagnosis drugs
January 17, 2020
Insurance status and access to care play an important role in racial disparities in stage of breast cancer at diagnosis, according to a study published online January in JAMA Oncology.
Quantum Leap Healthcare, G1 Therapeutics Announce Trilaciclib Evaluation americanpharmaceuticalreview
January 16, 2020
Quantum Leap Healthcare Collaborative™ and G1 Therapeutics announced a collaboration to evaluate trilaciclib, an investigational therapy designed to improve outcomes for people with cancer treated with chemotherapy, in a new randomized ...
NICE approves palbociclib with fulvestrant on the CDF for treatment of some breast cancers europeanpharmaceuticalreview
January 16, 2020
The NICE committee has made palbociclib with fulvestrant available on the Cancer Drug Fund for patients with hormone receptor-positive, HER2-negative, advanced breast cancer.
AI System Outperforms Radiologists in Breast Cancer Prediction drugs
January 03, 2020
An artificial intelligence (AI) system can reduce false positives and false negatives in prediction of breast cancer and outperforms human readers, according to a study published online Jan. 1 in Nature.
WHO announces first biosimilar medicine pre-qualification europeanpharmaceuticalreview
January 03, 2020
A trastuzumab biosimilar has been pre-qualified by WHO, marking its first, to improve access to the breast cancer treatment.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 26 27 Next page